Navigation Links
Egenix, Inc. Appoints Dr. Daniel Petrylak Chairman of Scientific Advisory Board
Date:4/8/2008

MILLBROOK, N.Y., April 8, 2008 /PRNewswire/ -- Donald C. Fresne, Chairman and CEO, Egenix, Inc., announced the appointment of Daniel Petrylak, MD as Chairman of the company's scientific advisory board. Dr. Petrylak is currently Associate Professor of Medicine at Columbia University Medical Center where he is Director of Genitourinary Oncology, Division of Medical Oncology. He is the co-author of numerous peer reviewed scientific papers and is a national leader in the treatment of cancers of prostate, kidney, and bladder. Dr. Petrylak stated, "I enthusiastically look forward to working with the Egenix team. I believe the company's initiatives for development of targeted translation inhibitors will reach the clinic in a timely fashion and provide unique benefits for patients with cancer."

About Egenix, Inc.

Based in Millbrook, New York, Egenix, Inc. is a privately held biotechnology company responding to the demand for more effective cancer therapies. Egenix is developing small molecule inhibitors of translation initiation, a new paradigm in target-specific, non-cytotoxic anti-cancer therapy, and the use of translation initiation-specific biomarkers to assess tumor sensitivity to anti-cancer therapy with this novel class of anti-cancer drugs.


'/>"/>
SOURCE Egenix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. NanoLogix Inc. Provides Financial Update, Appoints Bert Pharis as New Director
2. Observant LLC Appoints Two New Directors to the Senior Management Team
3. Immune Tolerance Institute Appoints Aaron B. Kantor Ph.D. Chief Scientific Officer
4. Light Sciences Oncology Appoints David P. Holveck to Its Board of Directors
5. IDM Pharma Appoints Gregory J. Tibbitts to Board of Directors
6. Caliper Life Sciences Appoints Peter F. McAree Senior Vice President and Chief Financial Officer
7. PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business
8. Touch Bionics appoints Head of Clinical Advocacy
9. Champions Biotechnology, Inc. Appoints New Board Members and Forms Management Team
10. Neurobiological Technologies Appoints Matthew M. Loar as Chief Financial Officer
11. NxStage Appoints Tom Shea as Senior Vice President of Manufacturing Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... Prairie, WI (PRWEB) , ... June 23, 2016 ... ... consultancy focused on quality, regulatory and technical consulting, provides a free webinar ... is presented on July 13, 2016 at 12pm CT at no charge. , ...
Breaking Biology Technology:
(Date:4/26/2016)... LONDON , April 26, 2016 ... a product subsidiary of Infosys (NYSE: ... to integrate the Onegini mobile security platform with ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration will ... to access and transact across channels. Using this ...
(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
Breaking Biology News(10 mins):